Evidence map›Paper›PMID 34737234›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease.

Manuj Ahuja, Navneet Ammal Kaidery, Otis C Attucks, Erin McDade, Dmitry M Hushpulian, Arsen Gaisin, Irina Gaisina, Young Hoon Ahn, Sergey Nikulin, Andrey Poloznikov and 6 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. A BACH1 inhibitor ameliorates myocardial infarction and limb ischemia in mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. HPPE Activates NRF2 Signaling by Liberating Heavy Metal Stores.Chembiochem : a European journal of chemical biology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Manuj AhujaDarby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425.
Navneet Ammal KaideryDarby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425.
Otis C AttucksvTv Therapeutics LLC, High Point, NC 27265.
Erin McDadevTv Therapeutics LLC, High Point, NC 27265.
Dmitry M HushpulianFaculty of Biology and Biotechnology, National Research University Higher School of Economics, Moscow 109028, Russia.ORCID 0000-0002-2171-9896
Arsen GaisinIntegrated Molecular Structure Education and Research Center, Northwestern University, IL 60208.
Irina GaisinaDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago, IL 60612.ORCID 0000-0002-8668-3222
Young Hoon AhnDepartment of Chemistry, Wayne State University, Detroit, MI 48202.ORCID 0000-0003-0765-3074
Sergey NikulinFaculty of Biology and Biotechnology, National Research University Higher School of Economics, Moscow 109028, Russia.
Andrey PoloznikovFaculty of Biology and Biotechnology, National Research University Higher School of Economics, Moscow 109028, Russia.ORCID 0000-0003-1816-8699
Irina GazaryanFaculty of Biology and Biotechnology, National Research University Higher School of Economics, Moscow 109028, Russia.
Masayuki YamamotoDepartment of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Mitsuyo MatsumotoDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.ORCID 0000-0002-2918-9893
Kazuhiko IgarashiDepartment of Biochemistry, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.ORCID 0000-0002-2470-2475
Sudarshana M SharmaDepartment of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425.
Bobby ThomasDarby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425; thomasbo@musc.edu.ORCID 0000-0001-9244-9726
Medical University of South Carolina · USNational Research University Higher School of Economics · RUTohoku University · JPvTv Therapeutics (United States) · USNorthwestern University · USUniversity of Illinois Urbana-Champaign · USWayne State University · US

Funding

Role of Bach-1-Mediated Transcriptional Regulation in NeuroprotectionR01NS101967 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI THOMAS, BOBBY · 2017 to 2021
$1.9M
Orbitrap Fusion Lumos ETD Mass SpectrometerS10OD025126 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2018 to 2018
$991k
NIH HHS S10 OD025126NINDS NIH HHS R01 NS101967
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neuroprotection1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAgedAged, 80 and overAnimalsAntioxidant Response ElementsBasic-Leucine Zipper Transcription FactorsCase-Control StudiesDisease Models, AnimalDrug Evaluation, PreclinicalFemaleHumansMaleMiceMice, KnockoutParkinson Disease1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineBACH1 protein, humanBasic-Leucine Zipper Transcription FactorsBach1MPTPNrf2Parkinson’s diseasetranscriptional repressor

Identifiers

PMID34737234
PMCPMC8694049
OpenAlexW3211210582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.